Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Neuraxis, Inc. (NRXS : AMEX)
 
 • Company Description   
NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis, Inc. is based in CARMEL, Ind.

Number of Employees: 21

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.58 Daily Weekly Monthly
20 Day Moving Average: 122,755 shares
Shares Outstanding: 7.22 (millions)
Market Capitalization: $18.62 (millions)
Beta: 3.09
52 Week High: $3.99
52 Week Low: $1.33
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.15% -5.54%
12 Week 44.13% 23.11%
Year To Date 9.79% 2.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
11611 N. Meridian Street Suite 330
-
Carmel,IN 46032
USA
ph: 812-689-0791
fax: -
ir@neuraxis.com https://neuraxis.com
 
 • General Corporate Information   
Officers
Brian Carrico - President; Chief Executive Officer; and Director
Bradley Mitch Watkins - Director and Chairman of the Board
Timothy Henrichs - Chief Financial Officer
Adrian Miranda - Chief Medical Officer; Senior Vice President of Sc
Christopher Robin Brown - Director

Peer Information
Neuraxis, Inc. (HLIS)
Neuraxis, Inc. (AZTA)
Neuraxis, Inc. (APYI)
Neuraxis, Inc. (RNVA)
Neuraxis, Inc. (HMSY)
Neuraxis, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 64134X201
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/08/25
Share - Related Items
Shares Outstanding: 7.22
Most Recent Split Date: (:1)
Beta: 3.09
Market Capitalization: $18.62 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 73.38
Price/Cash Flow: -
Price / Sales: 6.34
EPS Growth
vs. Year Ago Period: 3.12%
vs. Previous Quarter: -47.62%
Sales Growth
vs. Year Ago Period: 38.49%
vs. Previous Quarter: 17.74%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -297.92
12/31/24 - -347.76
Current Ratio
06/30/25 - -
03/31/25 - 1.21
12/31/24 - 1.75
Quick Ratio
06/30/25 - -
03/31/25 - 1.19
12/31/24 - 1.74
Operating Margin
06/30/25 - -
03/31/25 - -293.36
12/31/24 - -306.74
Net Margin
06/30/25 - -
03/31/25 - -293.36
12/31/24 - -306.74
Pre-Tax Margin
06/30/25 - -
03/31/25 - -286.10
12/31/24 - -306.85
Book Value
06/30/25 - -
03/31/25 - 0.04
12/31/24 - 0.30
Inventory Turnover
06/30/25 - -
03/31/25 - 11.61
12/31/24 - 11.16
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©